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While investigating the possible occurrence
of neutral plasmalogens in human blood, we
isolated a substance which had the same
chromatographic characteristics on thin-layer
chromatoplates as those of alkyl di-
glycerides. This substance was identified (1)
as di-2-ethylhexyl phthalate (DEHP), and we
were able to demonstrate (2) that this plas-
tifier originated from the plastic transfusion
packs which had contained the blood and
that its concentration increased with the
time of storage up to a level of about
11.5 mg/100 ml of plasma after 21 days.
These observations were confirmed by Jaeger
and Rubin (3), who have also shown that
DEPH accumulates in liver cells during the
perfusion of rat liver. These authors also
found that liver, spleen, lung, and abdominal
fat in two patients who had received blood
transfusions contained significant quantities
of DEHP.
In the present report, we describe a direct
method of determination of DEHP by gas-
liquid chromatography. With this method,
we have been able to demonstrate that the
leaching out of DEHP from plastic trans-
ufsion packs was correlated with the plasma
concentration of triglycerides. Also the
DEHP levels in cryoprecipitates, which are
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prepared from blood contained in plastic
transfusion packs, have been measured.
Methods
Blood Samples and Cryoprecipitates
The blood samples were taken with evacu-
ated glass tubes from transfusion blood bags
which had been stored for 24 days in a local
blood bank. The cryoprecipitates were
stored frozen in plastic transfusion packs
and had been prepared by the standard
method used by the Canadian Red Cross.
The cryoprecipitates were thawed at room
temperature and their liquid contents were
drained by gravity to be extracted for lipid
analysis.
Plasma Lipid Determination
The plasma concentration of triglycerides
was measured with the semi-automated
method of Kraml and Cosyns (4) and that
of total cholesterol was determined by the
method of Block et al. (5) with an auto-
analyzer.
Determination of DEHP Concentration
To an aliquot of plasma (1 ml), methanol
(5 ml) was added, followed by addition of
dipentyl phthalate or dipropyl phthalate as
an internal standard. For optimum accuracy,
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(100-400 ,g) is adjusted to be in the same
range as that of DEHP. Chloroform (5 ml)
was added and the mixture thoroughly
shaken. Then chloroform (2.5 ml) was added
and the mixture was shaken again. After
standing at room temperature for 30 min,
2.5 ml of NaCl solution (0.75%) was added,
and the two phases thus formed were slowly
inverted. After separation of the phases over-
night at 40C, the upper aqueous phase and
the proteins were removed by suction, and
the chloroform phase was evaporated under
a stream of nitrogen. The lipid extract thus
obtained was dissolved in chloroform
(100 ,l) and an aliquot (2 ,l) was injected in
a gas chromatograph equipped with a hydro-
gen flame detector and an electronic inte-
grator. For this analysis two stationary
phases were alternatively used: a polar phase
of diethylene glycol succinate packed in a
4-ft column which was operated isothermally
at 1950C or a nonpolar phase of dimethyl
silicone gum packed in a 2-ft column which
was operated at the initial temperature of
1750C with an increment of 20C/min. In
both cases, the separation was satisfactory,
and no lipid fraction was found to interfere
with the peaks of phthalates. The concentra-
tion of DEHP was then calculated from the
ratio of the peak areas of DEHP and from
the concentration of the internal standard.
Results and Discussion
We have determined the DEHP contents
and the cholesterol and triglyceride con-
centrations in 17 plasma samples which had
been stored for 24 days in plastic trans-
fusion packs, and the results are summarized
in Table 1. The levels of DEHP found in the
present study are significantly higher than
those reported previously (2). This dif-
ference is probably due to the fact that in
the previous study we had used preparative
thin-layer chromatography to enrich the
lipid extract in its DEHP content, a step
which causes losses in DEHP. There is a
strong positive correlation between the
DEHP levels and the triglyceride concentra-
Table 1. Lipid concentrations and DEHP levels in plasma
obtained from blood stored in plastic transfusion packs.
X ±S.D. Range
Triglycerides, mg/100 198 143 32-550
ml plasmaa
Total cholesterol, mg/ 160 18 136 - 192
100 ml plasmaa
DEHP, mg/100 ml 14.5 2.9 10.6 - 20.9
plasmaa
a(n = 17).
tions (r =0.649, p < 0.01), whereas there is
no correlation between DEHP and total
cholesterol. Therefore it appears that the
leaching out of DEHP is directly related to
the triglyceride content of plasma.
With the same method, we measured the
DEHP content in bags of cryoprecipitates
which are fractions rich in Factor VIII or
antihemophilic factor and which are ob-
tained from blood stored in plastic trans-
fusion packs. The analyses were done on
four cryoprecipitate packs, which contained
respectively, 0.8, 1.2, 1.5, and 1.9 mg of
DEHP. Although the DEHP content of cryo-
precipitate bags is much lower than that of
blood bags, this small concentration of
DEHP may represent a serious problem for
the hemophiliacs. Indeed many hemo-
philiacs, who are given a prophylactic or
maintenance treatment with cryoprecipitates,
receive about 400 bags of cryoprecipitates in
a 1-year period. Therefore over the years it
will be grams of DEHP that these patients
will have received and probably accumulated
in various organs. As Jaeger and Rubin have
already demonstrated, (3), DEHP does not
appear to be metabolized and can accumu-
late in tissues like spleen, liver, lungs, and
abdominal fat. Further, it is not certain that
all aspects of the possible toxicity of DEHP
have been investigated. Indeed, Rogers and
Dunn (6) have reported that several cases of
neonatal intestinal perforations which fol-
lowed exchange transfusions may be
attributable to substances such as plastifiers
which leached out from the perfusion equip-
ment.
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further studies on the presence and the ef-
fect of DEHP in human subjects and es-
pecially in haemophiliacs as well as in cases
of multiple perfusions.
REFERENCES
1. Marcel, Y. L., and Noel, S. P. 1970. A plas-
ticizer in lipid extracts of human blood.
Chem. Phys. Lipids 4: 418.
2. Marcel, Y. L., and Noel, S. P. 1970. Contam-
ination of blood stored in plastic packs.
Lancet 1: 35.
3. Jaeger, R. J., and Rubin, R. J. 1970. Plastic-
izers from plastic devices: extraction, metabo-
lism, and accumulation by biological systems.
Science 170: 460.
4. Kraml, M., and Cosyns, L. 1969. A semi-
automated determination of serum triglyc-
erides. Clin. Biochem. 2: 363.
5. Block, W. D., Jarret, K. J., and Levin, J. B.
1966. An improved automated determination
of serum total cholesterol with a single color
reagent. Clin. Chem. 12: 681.
6. Rogers, A. F., and Dunn, P.M. 1969. In-
testinal perforation, exchange transfusions,
and PVC. Lancet 2: 1246.
January 1973 121